Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Jun 9, 2010 sing george l Director Option Execute 5,000 25.43
May 30, 2012 sing george l Director Sell 5,000 134.00
May 31, 2012 sing george l Director Sell 5,000 134.74 - 135.15
Aug 22, 2012 sing george l Director Sell 5,000 139.00
Aug 22, 2012 sing george l Director Option Execute 5,000 18.80
Aug 23, 2012 sing george l Director Sell 5,000 142.00
Aug 23, 2012 sing george l Director Option Execute 5,000 18.80
Jul 26, 2012 sing george l Director Sell 5,000 135.00
Jul 26, 2012 sing george l Director Option Execute 5,000 18.80
Nov 22, 2011 sing george l Director Option Execute 15,000 28.81
Dec 17, 2012 sing george l Director Disposition (Non Open Market) 10,000 n/a
Dec 17, 2012 sing george l Director Acquisition (Non Open Market) 10,000 n/a
May 10, 2013 sing george l Director Sell 5,000 270.00
May 10, 2013 sing george l Director Option Execute 5,000 15.01
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Nov 16, 2012 sing george l Director Sell 5,000 152.00
Nov 13, 2012 sing george l Director Sell 5,000 148.00
May 6, 2013 tessier-lavigne marc Director Sell 13,334 260.20 - 264.17
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Aug 26, 2014 tessier-lavigne marc Director Disposition (Non Open Market) 200 351.62
Showing 301-320 of 863 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)